Mustafa ELİAÇIK

An Open Label Prospective Randomized Trial to Compare The Efficacy Tolerability and Cost Effectiveness of Brand Name Versus Two Different Generic Drug of Fixed Combination Dorzolamide 2% and Timolol 0.5% in The Treatment of Primary Open Angle Glaucoma

An Open Label Prospective Randomized Trial to Compare The Efficacy Tolerability and Cost Effectiveness of Brand Name Versus Two Different Generic Drug of Fixed Combination Dorzolamide 2% and Timolol 0.5% in The Treatment of Primary Open Angle Glaucoma

Medical Research Reports

2018-Cilt: 1 - Sayı: 3

55-60

generic drug, cost effectiveness, retrobulbar bloodflow, color doppler imaging

96 88